CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI

临床试验：研究疗效

• 批准号: 7724937
• 负责人: Bruce L. Zuraw
• 金额: $ 0.23万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724937
• 关键词: Clinical Trials; Complement component C1s; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Placebos; Research; Research Personnel; Resources; Safety; Source; Symptoms; Testing; Time; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine whether C1INH-nf treated subjects have shorter median time to relief of the defining symptoms compared to placebo. Test whether time to relief is different in subjects treated with C1INH-nr compared to placebo.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 确定与安慰剂相比，C1 INH-nf治疗受试者至定义症状缓解的中位时间是否更短。 检验接受C1 INH-nr治疗的受试者与接受安慰剂治疗的受试者相比，至缓解时间是否存在差异。